Ebola virus executes its replication cycle through a tightly orchestrated sequence of events, but the host factors that govern the timing of these steps have remained poorly defined. In this talk, I ...
A recent study published in PLOS Pathogens examined two newly identified nanobodies, Nanosota-EB1 and Nanosota-EB2, as potential inhibitors of the Ebola virus. The research evaluated the ability of ...
Scientists share detailed, complete images of a viral structure called the Ebola virus nucleocapsid. This breakthrough may accelerate the development of antivirals that target this viral structure to ...
Researchers at the University of Iowa (UI) Health Care and colleagues at the Texas Biomedical Research Institute, and Boston University, used human skin explants to track the cellular route that the ...
Lab-grown antibodies which can be given to patients to reinforce their immune response ...
Ervebo, an Ebola vaccine, is neither experimental, nor contains the Ebola virus. A different virus used in the vaccine, vesicular stomatitis, can shed. Denver health care workers who received the ...
Holly has a degree in Medical Biochemistry from the University of Leicester. Her scientific interests include genomics, personalized medicine, and bioethics.View full profile Holly has a degree in ...
To study how Ebola virus moves through skin, the explants were placed dermal side down in culture media and virus particles were added to the media so that they entered the skin from the underside, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results